Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Domenico Orlando
Observed name:
D. Orlando
Institutions:
Bambino Gesù Children's Hospital,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Bambino Gesù Children's Hospital,
Istituti di Ricovero e Cura a Carattere Scientifico,
Harold C. Simmons Comprehensive Cancer Center,
The University of Texas Southwestern Medical Center
ORCID:
0000-0002-4088-941X
Observed ORCID:
0000-0002-4088-941X
OpenAlex ID:
A5006517030
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma
2018
·
Concetta Quintarelli
, Domenico Orlando
, et al.
·
OncoImmunology
·
177
PDF
Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma
2023
·
Ester Álvarez‐Benedicto
, Zeru Tian
, et al.
·
Angewandte Chemie International Edition
·
160
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
2019
·
C. Quintarelli
, S. Sivori
, et al.
·
Leukemia
·
101
Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma
2018
·
Domenico Orlando
, Evelina Miele
, et al.
·
Cancer Research
·
85
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
2021
·
Emmanuel de Billy
, Marsha Pellegrino
, et al.
·
Neuro-Oncology
·
84
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells
2020
·
Marika Guercio
, Domenico Orlando
, et al.
·
Haematologica
·
76
PDF
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
·
Clinical Cancer Research
·
60
PDF
Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
2018
·
Virginia Di Paolo
, Ida Russo
, et al.
·
BMC Cancer
·
28
PDF
Spleen SORT LNP Generated in situ CAR T Cells Extend Survival in a Mouse Model of Lymphoreplete B Cell Lymphoma
2023
·
Ester Álvarez‐Benedicto
, Zeru Tian
, et al.
·
Angewandte Chemie
·
17
CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells
2018
·
Concetta Quintarelli
, Simona Sivori
, et al.
·
Blood
·
12
A New Promising Third Generation CAR-CD30 T-Cell Therapy for CD30+ Lymphoma
2019
·
Biagio De Angelis
, Marika Guercio
, et al.
·
Blood
·
2
Immu-13. Dual Igf1r/ir Inhibitor in Combination With Gd2-car T-cells as a Potent Therapeutic Strategy for H3k27m-mutant Diffuse Midline Gliomas
2020
·
Emmanuel de Billy
, Marsha pellegrino
, et al.
·
Neuro-Oncology
·
1
PDF
Supplemental Figure 12 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 5 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Data from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 6 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 14 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Video 2 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 8 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
PDF
Supplemental Figure 17 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 2 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 16 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 13 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 4 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Supplemental Figure 3 from GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024
·
Roselia Ciccone
, Concetta Quintarelli
, et al.
Show more works
View as search
Works count:
36
Citation count:
803
H-index:
10
I10-index:
10
Year
Topic
Type